Decreased Renal Function Is a Risk Factor for Subclinical Coronary Atherosclerosis in Korean Postmenopausal Women
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: Decreased renal function is associated with increased cardiovascular risk. Our study was planned to verify the association of decreased renal function and subclinical coronary atherosclerosis in postmenopausal women.Methods: We performed a retrospective review of 251 Korean postmenopausal women who visited the health promotion center for a routine health checkup. Estimated glomerular filtration rate (eGFR) was used to show renal function, which was estimated by calculated using the Cockcroft-Gault (CG) and the modification of diet in renal disease (MDRD) formulas. Coronary atherosclerosis was assessed by 64-row multidetector computed tomography.Results: Women with reduced eGFR (< 60 mL/minute/1.73 m2) had significantly higher brachial-ankle pulse wave velocity (baPWV) than women with normal eGFR (≥ 60 mL/minute/1.73 m2). The eGFR was negatively correlated with baPWV (r = -0.352, P < 0.001), significantly. The eGFR was lower in women with coronary atherosclerosis than in normal control women, markedly. Reduced eGFR was significantly associated with the presence of coronary atherosclerosis (odds ratio [OR] = 7.528, 95% confidence interval [CI] = 2.728-20.772, P < 0.001).Conclusions: Decreased eGFR was closely associated with increased arterial stiffness and coronary atherosclerosis in postmenopausal women. Evaluating subclinical atherosclerosis by screening the renal function in postmenopausal women may be helpful screening high risk group and considering starting menopausal hormone therapy before atherosclerosis development. (J Menopausal Med 2016;22:167-173)
Abstract
Objectives: Decreased renal function is associated with increased cardiovascular risk. Our study was planned to verify the association of decreased renal function and subclinical coronary atherosclerosis in postmenopausal women.Methods: We performed a retrospective review of 251 Korean postmenopausal women who visited the health promotion center for a routine health checkup. Estimated glomerular filtration rate (eGFR) was used to show renal function, which was estimated by calculated using the Cockcroft-Gault (CG) and the modification of diet in renal disease (MDRD) formulas. Coronary atherosclerosis was assessed by 64-row multidetector computed tomography.Results: Women with reduced eGFR (< 60 mL/minute/1.73 m2) had significantly higher brachial-ankle pulse wave velocity (baPWV) than women with normal eGFR (≥ 60 mL/minute/1.73 m2). The eGFR was negatively correlated with baPWV (r = -0.352, P < 0.001), significantly. The eGFR was lower in women with coronary atherosclerosis than in normal control women, markedly. Reduced eGFR was significantly associated with the presence of coronary atherosclerosis (odds ratio [OR] = 7.528, 95% confidence interval [CI] = 2.728-20.772, P < 0.001).Conclusions: Decreased eGFR was closely associated with increased arterial stiffness and coronary atherosclerosis in postmenopausal women. Evaluating subclinical atherosclerosis by screening the renal function in postmenopausal women may be helpful screening high risk group and considering starting menopausal hormone therapy before atherosclerosis development. (J Menopausal Med 2016;22:167-173)
참고문헌 (21)
- von der Recke P, "The association between low bone mass at the menopause and cardiovascular mortality", Am J Med, 106, pp.273~278 (1999)
- Anderson GL, "Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial", JAMA, 291, pp.1701~1712 (2004)
- Clarke SC, "A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study", BJOG, 109, pp.1056~1062 (2002)
- Hulley S, "Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen", progestin Replacement Study (HERS) Research Group, 1998, pp.280, 605~613
- Rossouw JE, "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial", JAMA, 288, pp.321~333 (2002)
- Rossouw JE, "Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause", JAMA, 297, pp.1465~1477 (2007)
- Mendelsohn ME, "Molecular and cellular basis of cardiovascular gender differences", Science, 308, pp.1583~1587 (2005)
- Kurth T, "Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study", BMJ, 338, pp.b2392~ (2009)
- Jung YS, "Renal function is associated with bone mineral density and arterial stiffness in healthy postmenopausal women", Gynecol Obstet Invest, 78, pp.124~129 (2014)
- Seo SK, "Bone mineral density, arterial stiffness, and coronary atherosclerosis in healthy postmenopausal women", Menopause, 16, pp.937~943 (2009)
- Yun BH, "Association of metabolic syndrome with coronary atherosclerosis in non-diabetic postmenopausal women", Climacteric, 18, pp.284~289 (2015)
- Achenbach S, "Detection of calcified and noncalcified coronary atherosclerotic plaque by contrast-enhanced, submillimeter multidetector spiral computed tomography: a segment-based comparison with intravascular ultrasound", Circulation, 109, pp.14~17 (2004)
- 이순신, "Application of Bioactive Natural Materials-based Products on Five Women’s Diseases", 대한폐경학회지, 21(3), pp.121~125 (2015), 대한폐경학회
- Kawsar Ahmed, "Assessment of Menopausal Symptoms among Early and Late Menopausal Midlife Bangladeshi Women and Their Impact on the Quality of Life", 대한폐경학회지, 22(1), pp.39~46 (2016), 대한폐경학회
- Jeon GH, "The association between serum estradiol level and coronary artery calcification in postmenopausal women: a preliminary report", J Korean Soc Menopause, 16, pp.16~22 (2010)
- Viazzi F, "Microalbuminuria in primary hypertension: a guide to optimal patient management?", J Nephrol, 29, pp.747~753 (2016)
- Pedrinelli R, "Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension", J Hum Hypertens, 16, pp.79~89 (2002)
- Leoncini G, "Mild renal dysfunction and cardiovascular risk in hypertensive patients", J Am Soc Nephrol, 15(Suppl 1), pp.S88~S90 (2004)
- Choi SW, "eGFR is associated with subclinical atherosclerosis independent of albuminuria: the Dong-gu Study", Atherosclerosis, 212, pp.661~667 (2010)
- Astor BC, "Association of kidney function and hemoglobin with left ventricular morphology among African Americans: the Atherosclerosis Risk in Communities (ARIC) study", Am J Kidney Dis, 43, pp.836~845 (2004)
- Miyatake N, "Relation between the estimated glomerular filtration rate and pulse wave velocity in Japanese", Intern Med, 49, pp.1315~1320 (2010)